IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Regeneron Pharmaceuticals, Inc.

Q2 2025 Holdings

Filed 2025-08-01 | 4 holdings | $1.5B | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Alnylam Pharmaceuticals, Inc.(ALNY)Common Stock02043Q107$1.4B4,444,44597.6%
Intellia Therapeutics, Inc.(NTLA)Common Stock45826J105$34.7M3,702,9952.3%
Adicet Bio, Inc.(TORCEUR)Common Stock007002108$590.6K968,1830.0%
Adverum Biotechnologies, Inc.(AVU0)Common Stock00773U207$389.0K180,9090.0%